Back to Search Start Over

The immune health metric as an indicator of health and disease.

Authors :
Kubo S
Tanaka Y
Source :
Nature reviews. Rheumatology [Nat Rev Rheumatol] 2024 Dec; Vol. 20 (12), pp. 743-744.
Publication Year :
2024

Abstract

Competing Interests: Competing interests: S.K. has received speaking fees from Eli Lilly, GlaxoSmithKline, Abbvie, Bristol-Myers, Astra-Zeneca, Boehringer Ingelheim and Eisai, and research grants from Daiichi-Sankyo, Abbvie, Boehringer Ingelheim and Astellas. Y. T. has received speaking fees or honoraria from Abbvie, Eisai, Chugai, Eli-Lilly, Boehringer Ingelheim, GlaxoSmithKline, Taisho, AstraZeneca, Daiichi-Sankyo, Gilead, Pfizer, UCB, Asahi-kasei and Astellas, and research grants from Boehringer Ingelheim, Taisho and Chugai.

Details

Language :
English
ISSN :
1759-4804
Volume :
20
Issue :
12
Database :
MEDLINE
Journal :
Nature reviews. Rheumatology
Publication Type :
Academic Journal
Accession number :
39232241
Full Text :
https://doi.org/10.1038/s41584-024-01162-0